Capital Fund Management (CFM)
COLL icon

Capital Fund Management (CFM)’s Collegium Pharmaceutical COLL Stock Holding History

Capital Fund Management (CFM)’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-19,400
Closed -$286K – 1898
2018
Q3 		$286K Buy
+19,400
New +$344K ﹤0.01% 1779

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital Fund Management (CFM)'s COLL Position: Q4 2018 in Review

Capital Fund Management (CFM) sold out of Collegium Pharmaceutical (COLL) in Q4 2018, closing a stake of 19,400 shares — an estimated $286K sold.

Capital Fund Management (CFM) first reported a position in COLL in Q3 2018 and held it in 1 quarter. The position peaked at $286K in Q3 2018. 120 funds tracked by Wall St. Rank hold COLL as of Q4 2018.

  • Capital Fund Management (CFM) reported no remaining Collegium Pharmaceutical position as of Q4 2018 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 19,400 Collegium Pharmaceutical shares in Q4 2018, an estimated $286K.
  • Capital Fund Management (CFM) first reported a position in Collegium Pharmaceutical in Q3 2018 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Collegium Pharmaceutical position peaked at $286K in Q3 2018.
  • 120 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2018.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2018, filed 13 Feb 2019.